ORYZON to Present New Clinical Data and Corporate Updates at International Conferences in May and June
BioEquity Europe Digital Oxford Global’s Online Drug Discovery Week Jefferies Virtual Healthcare Conference 2021 Precision in…
BioEquity Europe Digital Oxford Global’s Online Drug Discovery Week Jefferies Virtual Healthcare Conference 2021 Precision in…
LA JOLLA, Calif., May 13, 2021 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a clinical-stage…
Experienced Biotech Executive, Physician-Scientist and Orphan Disease Expert to Lead Clinical/Medical Functions as Seladelpar Advances…
SAN CARLOS, Calif., May 13, 2021 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a leader in…
MONTREAL, May 13, 2021 (GLOBE NEWSWIRE) — Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical…
Experienced Biotech Executive, Physician-Scientist and Orphan Disease Expert to Lead Clinical/Medical Functions as Seladelpar Advances…
Interim analysis from the ongoing, open-label, randomized acute viral pneumonia (including COVID-19) pilot study shows…
SEL-399 (empty AAV8 capsid with ImmTOR) study on track with topline data expected in the…
SOUTH SAN FRANCISCO, Calif., May 13, 2021 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO)…
MONTREAL, May 13, 2021 (GLOBE NEWSWIRE) — Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical…
WAKEFIELD, Mass., May 13, 2021 (GLOBE NEWSWIRE) — Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical…
Experienced Biotech Executive, Physician-Scientist and Orphan Disease Expert to Lead Clinical/Medical Functions as Seladelpar Advances…
Raised net proceeds of $27.9 million in U.S. initial public offering in February 2021 Lead…
SEL-399 (empty AAV8 capsid with ImmTOR) study on track with topline data expected in the…
CAMBRIDGE, Mass., May 13, 2021 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset…
SEL-399 (empty AAV8 capsid with ImmTOR) study on track with topline data expected in the…
Raised net proceeds of $27.9 million in U.S. initial public offering in February 2021 Lead…
SAN DIEGO, May 13, 2021 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage…
MONTREAL, May 13, 2021 (GLOBE NEWSWIRE) — Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical…
Raised net proceeds of $27.9 million in U.S. initial public offering in February 2021 Lead…